Renix Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
2ndary - Private
- Investors
-
5
Renix General Information
Description
Developer of a liquid separation technology intended to purify materials for daily use. The company offers a steady-state ion exchange technology with advanced separation processes and application-specific engineering capabilities to improve liquid separation and purification processes, enabling industrial operators to recover materials more efficiently, reduce waste, and improve process performance and resource utilization.
Contact Information
Website
www.renix.caCorporate Office
- 316 Rectory Street
- London, Ontario N5W 3V9
- Canada
Corporate Office
- 316 Rectory Street
- London, Ontario N5W 3V9
- Canada
Renix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Secondary Transaction - Private | 01-Oct-2023 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 21-Jan-2022 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 27-May-2019 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 24-May-2019 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 21-Sep-2016 | Completed | Generating Revenue | |||
| 2. Grant | 30-Nov-2012 | $49.2K | $498K | Completed | Generating Revenue | |
| 1. Angel (individual) | $498K | $498K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Renix Patents
Renix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024223141-A1 | Protein recovery method | Pending | 15-Feb-2023 | ||
| EP-4665740-A1 | Protein recovery method | Pending | 15-Feb-2023 | ||
| US-20260317371-A1 | Protein recovery method | Pending | 15-Feb-2023 | ||
| WO-2024168422-A1 | Protein recovery method | Inactive | 15-Feb-2023 | ||
| US-20140076816-A1 | Apparatus and circulating fluidized bed system | Active | 06-May-2011 | B01J47/10 |
Renix Signals
Renix Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ClonBio | Corporation | Minority | ||
| MaRS Investment Accelerator Fund | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Southwestern Ontario Angel Group | Angel Group | Minority | ||
| National Sciences and Engineering Research Council of Canada | Government |
Renix FAQs
-
When was Renix founded?
Renix was founded in 2009.
-
Where is Renix headquartered?
Renix is headquartered in London, Canada.
-
What is the size of Renix?
Renix has 15 total employees.
-
What industry is Renix in?
Renix’s primary industry is Other Equipment.
-
Is Renix a private or public company?
Renix is a Private company.
-
What is Renix’s current revenue?
The current revenue for Renix is .
-
How much funding has Renix raised over time?
Renix has raised $1.69M.
-
Who are Renix’s investors?
ClonBio, MaRS Investment Accelerator Fund, , Southwestern Ontario Angel Group, and National Sciences and Engineering Research Council of Canada have invested in Renix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process